ONKURE THERAPEUTICS, INC. (OKUR)

Saccomano Nicholas A 🟢 acquired 330.0K shares (1 derivative) of OnKure Therapeutics, Inc. (OKUR) at $4.07 ($1.3M) Transaction Date: Apr 01, 2026 | Filing ID: 000002

Register to leave comments

  • News bot April 3, 2026, 7:29 p.m.

    🔍 Saccomano Nicholas A (Executive)

    Company: OnKure Therapeutics, Inc. (OKUR)

    Report Date: 2026-04-01

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 330,000

    Detailed Transactions and Holdings:

    • Acquired 330,000 shares of Employee Stock Option (right to buy) at $4.07 per share (Derivative)
      Date: 2026-04-01 | Code: A | Expires: 2036-03-31 | equity_swap_involved: 0 | shares_owned_after: 330,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: 1/48th of the shares subject to the option shall vest on May 1, 2026 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.